Extract from the Register of European Patents

EP About this file: EP2848610

EP2848610 - Inhibitors of kinase activity [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  17.08.2018
Database last updated on 31.03.2026
FormerThe patent has been granted
Status updated on  08.09.2017
FormerGrant of patent is intended
Status updated on  15.06.2017
FormerExamination is in progress
Status updated on  23.05.2017
FormerGrant of patent is intended
Status updated on  18.01.2017
Most recent event   Tooltip17.08.2018No opposition filed within time limitpublished on 19.09.2018  [2018/38]
Applicant(s)For all designated states
YM BioSciences Australia Pty Ltd
2nd Floor 499 St Kilda Road
Melbourne, VIC 3004 / AU
[2015/12]
Inventor(s)01 / Burns, Christopher John
576 Swan Street
Richmond, Victoria 3121 / AU
02 / Harte, Michael Francis
576 Swan Street
Richmond, Victoria 3121 / AU
03 / Palmer, James T.
576 Swan Street
Richmond, Victoria 3121 / AU
 [2015/12]
Representative(s)Schnappauf, Georg, et al
ZSP Patentanwälte PartG mbB
Hansastraße 32
80686 München / DE
[2017/41]
Former [2015/12]Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
Application number, filing date14181447.515.11.2007
[2015/12]
Priority number, dateAU2006906359P15.11.2006         Original published format: AU 2006906359 P
US20070901512P14.02.2007         Original published format: US 901512 P
[2015/12]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2848610
Date:18.03.2015
Language:EN
[2015/12]
Type: B1 Patent specification 
No.:EP2848610
Date:11.10.2017
Language:EN
[2017/41]
Search report(s)(Supplementary) European search report - dispatched on:EP12.02.2015
ClassificationIPC:C07D241/20, A61K31/427, A61K31/44, A61K31/497, A61K31/5377, C07D213/75, C07D403/04, C07D403/12, C07D403/14, C07D409/14, C07D413/10, C07D413/12, C07D417/12
[2015/12]
CPC:
C07D241/20 (EP,US); A61P1/04 (EP); A61P13/00 (EP);
A61P13/12 (EP); A61P17/06 (EP); A61P19/00 (EP);
A61P19/08 (EP); A61P19/10 (EP); A61P25/28 (EP);
A61P29/00 (EP); A61P3/00 (EP); A61P3/10 (EP);
A61P35/00 (EP); A61P35/02 (EP); A61P37/02 (EP);
A61P37/08 (EP); A61P43/00 (EP); A61P7/00 (EP);
A61P9/00 (EP); C07D213/75 (EP,US); C07D213/82 (EP,US);
C07D241/18 (EP,US); C07D241/24 (EP,US); C07D241/28 (EP,US);
C07D401/04 (EP,US); C07D401/12 (EP,US); C07D401/14 (EP,US);
C07D403/04 (EP,US); C07D403/12 (EP,US); C07D403/14 (EP,US);
C07D405/12 (EP,US); C07D405/14 (EP,US); C07D409/14 (EP,US);
C07D413/12 (EP,US); C07D417/12 (EP,US); C07F9/65583 (US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2015/44]
Former [2015/12]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MT,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:Inhibitoren der Kinaseaktivität[2015/12]
English:Inhibitors of kinase activity[2015/12]
French:Inhibiteurs de l'activité de kinase[2015/12]
Examination procedure18.09.2015Amendment by applicant (claims and/or description)
18.09.2015Examination requested  [2015/44]
15.04.2016Despatch of a communication from the examining division (Time limit: M04)
18.08.2016Reply to a communication from the examining division
19.01.2017Communication of intention to grant the patent
17.05.2017Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
17.05.2017Fee for grant paid
17.05.2017Fee for publishing/printing paid
12.06.2017Communication of intention to grant the patent
06.09.2017Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP07815564.5  / EP2099774
Divisional application(s)EP15195727.1  / EP3048099
Opposition(s)12.07.2018No opposition filed within time limit [2018/38]
Fees paidRenewal fee
19.08.2014Renewal fee patent year 03
19.08.2014Renewal fee patent year 04
19.08.2014Renewal fee patent year 05
19.08.2014Renewal fee patent year 06
19.08.2014Renewal fee patent year 07
31.08.2014Renewal fee patent year 08
30.11.2015Renewal fee patent year 09
28.11.2016Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipMC11.10.2017
[2018/36]
Documents cited:Search[X] WO03099796  (CYTOPIA PTY LTD et al.)
by applicant  HARTWIG, J.F., ANGEW. CHEM. INT. ED., vol. 37, 1998, pages 2046
   MIYAURA, N.; SUZUKI, CHEM REV., vol. 95, 1995, pages 2457
   STILLE, J.K., ANGEW. CHEM., INT. ED. ENGL., vol. 25, 1986, pages 508
   KUMADA, M.; TAMAO, K.; SUMITANI, K., ORG. SYNTH., vol. 6, 1988, pages 407
   NEGISHI, E., J. ORGANOMET. CHEM., vol. 653, 2002, pages 34
   J. MARCH: "Advanced Organic Chemistry: Reactions, Mechanisms and Structure", 1992, JOHN WILEY & SONS, pages: 352 - 357
   "Remington: The Science and Practice of Pharmacy", 2005, LIPPINCOTT WILLIAMS & WILKINS
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.